Currently out of the existing stock ratings of Jeffrey Holford, 73 are a BUY (79.35%), 17 are a HOLD (18.48%), 2 are a SELL (2.17%).

Jeffrey Holford

Work Performance Price Targets & Ratings Chart

Analyst Jeffrey Holford, carries an average stock price target met ratio of 98.61% that have a potential upside of 48.56% achieved within 1056 days. Previously, Jeffrey Holford worked at JEFFERIES.

Jeffrey Holford’s has documented 139 price targets and ratings displayed on 9 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on MRK, Merck mpany at 14-Feb-2018.

Wall Street Analyst Jeffrey Holford

Analyst best performing recommendations are on ABBV (ABBVIE).
The best stock recommendation documented was for ABBV (ABBVIE) at 2/22/2016. The price target of $80 was fulfilled within 704 days with a profit of $42.88 (115.52%) receiving and performance score of 1.64.

Average potential price target upside

of $44.49 (102.12%) on ABBV (ABBVIE).
of $37.98 (35.21%) on JNJ (JOHNSON & JOHNSON).
of $31.91 (48.51%) on LLY (ELI LILLY AND COMPANY).

ABBV AbbVie ABT Abbott Laboratories AZN AstraZeneca PLC ADR BMY Bristol-Myers Squibb Company LLY Eli Lilly and Company MRK Merck mpany PFE Pfizer JNJ Johnson & Johnson ZTS Zoetis

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Geoff Meacham (CITI)